Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study.

Saved in:
Bibliographic Details
Title: Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study.
Authors: Layton JB; Pharmacoepidemiology and Risk Management, RTI Health Solutions, 3040 East Cornwallis Road, Post Office Box 12194, Research Triangle Park, NC, 27709-2194, USA. jblayton@rti.org., Forns J; Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain., McQuay LJ; Pharmacoepidemiology and Risk Management, RTI Health Solutions, 3040 East Cornwallis Road, Post Office Box 12194, Research Triangle Park, NC, 27709-2194, USA., Danysh HE; Pharmacoepidemiology and Risk Management, RTI Health Solutions, Waltham, MA, USA., Dempsey C; Drug Safety and Pharmacovigilance, Acadia Pharmaceuticals Inc, Princeton, NJ, USA., Anthony MS; Pharmacoepidemiology and Risk Management, RTI Health Solutions, 3040 East Cornwallis Road, Post Office Box 12194, Research Triangle Park, NC, 27709-2194, USA., Turner ME; Drug Safety and Pharmacovigilance, Acadia Pharmaceuticals Inc, Princeton, NJ, USA.
Source: Drug safety [Drug Saf] 2023 Feb; Vol. 46 (2), pp. 195-208. Date of Electronic Publication: 2022 Dec 14.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1179-1942
DOI:10.1007/s40264-022-01260-6